International Psychedelic drugs market awaits nearly 100% revenue expansion by 2026 end: Fairfield The market researcher anticipates a 14.5% CAGR during the 2021-2026 forecast period Rowan DunneOctober 20, 2022
News ASKP3 Patient Portal to offer accurate fact-based info on ketamine Platform is intended to educate patients and medical providers on benefits of ketamine for treating pain and mood disorders Rowan DunneOctober 14, 2022
Psychedelics Choose Ketamine now offering at-home treatments in several states Company intends to provide ketamine therapy at a much lower price than a visit to the clinic would cost Rowan DunneOctober 4, 2022
Psychedelics Silo Pharma prepares pre-IND package for FDA on novel ketamine formulation Company will collaborate with Premier Consulting as regulatory partner and utilize Zylö Therapeutics Z-Pod technology Rowan DunneOctober 3, 2022
Canada Numinus launches ketamine-assisted therapy in Toronto Neurology Centre of Toronto in Forest Hill expands its therapy catalogue Rowan DunneSeptember 21, 2022
Canada Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada Rowan DunneSeptember 2, 2022
Psychedelics WITHIN ‘Ceremonial Psychedelic Treatment Center’ opens in Texas New clients offer detailed enthusiastic feedback thus far Rowan DunneAugust 2, 2022
Analysis Psychedelic therapeutics market to have steady growth: InsightAce Clinical psychedelic sector value anticipated to ascend significantly into 2028 Rowan DunneJuly 19, 2022
Business Field Trip Health opens clinic in Vancouver: Q&A with founder Ronan Levy The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services Nick LabaDecember 8, 2021
News California Senate passes psychedelic decriminalization bill If Bill SB-519 passes, possession of psychedelics for personal would be decriminalized, but cultivation and sale is still outlawed Natalia Buendia CalvilloJune 2, 2021